<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the neuroprotective evaluation, the neurogrowth effects in H
 <sub>2</sub>O
 <sub>2</sub> of the five extracts in PC12 were evaluated. The extracts that had the best neuroprotective effects were CPE, URE, and SSE in the concentrations ranging from 0.5 to 5.0 
 <italic>μ</italic>g/mL, with a percentage of neuroprotection from 78.1 to 107.2% for CPE, 54.1 to 85.7% for URE, and 46.3 to 65.7% for SSE, compared to the positive control AC-DEVDCHO (N-acetyl-Asp-Glu-Val-Asp-al) with values from 23.9 to 37.5%. Therefore, the extracts have the potential to be deepened into 
 <italic>in vivo</italic> studies for the treatment of neurodegenerative diseases, in which ALS is included [
 <xref rid="B91" ref-type="bibr">91</xref>].
</p>
